Evaluation of the Insulin-like Growth Factor Receptor Pathway in Patients with Advanced Breast Cancer Treated with Trastuzumab

Background: Trastuzumab is a monoclonal antibody against HER2-positive breast cancer. Despite improving the natural history of the disease, there is a number of patients who are resistant to it, whereas all patients will eventually develop resistance and disease will progress. Inconsistent preclinic...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Cancer Genomics Proteomics
Main Authors: CHRISTODOULOU, CHRISTOS, OIKONOMOPOULOS, GEORGIOS, KOLIOU, GEORGIA ANGELIKI, KOSTOPOULOS, IOANNIS, KOTOULA, VASSILIKI, BOBOS, MATTHEOS, PENTHEROUDAKIS, GEORGE, LAZARIDIS, GEORGE, SKONDRA, MARIA, CHRISAFI, SOFIA, KOUTRAS, ANGELOS, BAFALOUKOS, DIMITRIOS, RAZIS, EVANGELIA, PAPADOPOULOU, KYRIAKI, PAPAKOSTAS, PAVLOS, KALOFONOS, HARALAMBOS P, PECTASIDES, DIMITRIOS, SKARLOS, PANTELIS, KALOGERAS, KONSTANTINE T, FOUNTZILAS, GEORGE
פורמט: Artigo
שפה:Inglês
יצא לאור: International Institute of Anticancer Research 2018
נושאים:
Research Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC6299784/
https://ncbi.nlm.nih.gov/pubmed/30343280
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/cgp.20105
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים